Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of praziquantel versus As+SMP
(Co-Arinate FDC ®) in the treatment of Schistosoma haematobium in 6-15 year old Malian
children. The nul-hypothesis in this study is that the combination of As+SMP is more
effective than praziquantel in the treatment of S. haematobium infected children.